Yajun Geng

Yajun Geng


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
CJChengkai Jiang
Chengkai Jiang
YLYang Li
Yang Li
YLYongsheng Li
Yongsheng Li
LLLiguo Liu
Liguo Liu
XWXu-An Wang
Xu-An Wang
YLYing Bin Liu
Ying Bin Liu

20 February 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WLWeijian Li
Weijian Li
LZLu Zou
Lu Zou
SHShuai Huang
Shuai Huang
HMHuijie Miao
Huijie Miao
KLKe Liu
Ke Liu
WWWenguang Wu
Wenguang Wu
Bile acids (BAs) constitute essential components of cholesterol metabolites that are synthesized in the liver, stored in the gallbladder, and excreted into the intestine through the biliary system. They play a crucial role in nutrient absorption, lipid and glucose regulation, and the maintenance of metabolic homeostasis. In additional, BAs have demonstrated the ability to attenuate disease progression such as diabetes, metabolic disorders, heart disease, and respiratory ailments. Intriguingly, recent research has offered exciting evidence to unveil their potential antitumor properties against various cancer cell types including tamoxifen-resistant breast cancer, oral squamous cell carcinoma, cholangiocarcinoma, gastric cancer, colon cancer, hepatocellular carcinoma, prostate cancer, gallbladder cancer, neuroblastoma, and others. Up to date, multiple laboratories have synthesized novel BA derivatives to develop potential drug candidates. These derivatives have exhibited the capacity to induce cell death in individual cancer cell types and display promising anti-tumor activities. This review extensively elucidates the anticancer activity of natural BAs and synthetic derivatives in cancer cells, their associated signaling pathways, and therapeutic strategies. Understanding of BAs and their derivatives activities and action mechanisms will evidently assist anticancer drug discovery and devise novel treatment.

26 June 2024 in Cancer Letters
Verified
Journal Article
Closed access
JYJiahua Yang
Jiahua Yang
XLXuechuan Li
Xuechuan Li
SCShili Chen
Shili Chen
GLGuoqiang Li
Guoqiang Li
PPPeng Pu
Peng Pu
YLYing Bin Liu
Ying Bin Liu

7 May 2024 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
SLShujie Liu
Shujie Liu
WLWeijian Li
Weijian Li
JCJun Chen
Jun Chen
MLMaolan Li
Maolan Li
YGYajun Geng
Yajun Geng
WWWenguang Wu
Wenguang Wu
Gallbladder cancer (GBC) is the most common malignant tumor of the biliary system with the worst prognosis. Even after radical surgery, the majority of patients with GBC have difficulty achieving a clinical cure. The risk of tumor recurrence remains more than 65%, and the overall 5-year survival rate is less than 5%. The gut microbiota refers to a variety of microorganisms living in the human intestine, including bacteria, viruses and fungi, which profoundly affect the host state of general health, disease and even cancer. Over the past few decades, substantial evidence has supported that gut microbiota plays a critical role in promoting the progression of GBC. In this review, we summarize the functions, molecular mechanisms and recent advances of the intestinal microbiota in GBC. We focus on the driving role of bacteria in pivotal pathways, such as virulence factors, metabolites derived from intestinal bacteria, chronic inflammatory responses and ecological niche remodeling. Additionally, we emphasize the high level of correlation between viruses and fungi, especially EBV and Candida spp., with GBC. In general, this review not only provides a solid theoretical basis for the close relationship between gut microbiota and GBC but also highlights more potential research directions for further research in the future.

8 December 2025 in Cancer Letters
Verified
Journal Article
Closed access
XLXuechuan Li
Xuechuan Li
KLKe Liu
Ke Liu
LLLin Li
Lin Li
SYSiyuan Yan
Siyuan Yan
YYYue Yang
Yue Yang
XWXiangsong Wu
Xiangsong Wu